A carregar...
Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada
To investigate a potential risk for multiple sclerosis (MS) after vaccination with Arepanrix, the GlaxoSmithKline AS03-adjuvanted influenza A(H1N1)pdm09 vaccine, we used the provincewide immunization registry for Manitoba, Canada, to match 341,347 persons vaccinated during the 2009 pandemic to 485,9...
Na minha lista:
| Publicado no: | Emerg Infect Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Centers for Disease Control and Prevention
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6038732/ https://ncbi.nlm.nih.gov/pubmed/29912696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2407.161783 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|